Delivery Order SPE2DB25D3306-SPE2DB25FUCUG
- Not listed
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.89 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (8-count package) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,297.42 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (8-count package) on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitive award, issued without set-aside designation, reflects a firm fixed-price delivery order for pharmaceutical supply. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a $2,650.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was made without a set-aside designation...
- The Defense Logistics Agency awarded a $1,967.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 8, 2025, with completion targeted for September 9, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $2,285.22 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on July 29, 2025, with completion targeted for July 30, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,151.91 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 MCG vaginal inserts (8-count package). This is a firm fixed-price delivery order with no set-aside designation, issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCUGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,163.80 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and the place of performance is also located in Conshohocken. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp's prime IDC with the Defense Logistics Agency enables the company to supply pharmaceutical products and medical supplies to support military healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated significant capability in fulfilling federal medical procurement requirements through multiple competitive delivery orders covering a wide range of therapeutic domains. This particular order for Yuvafem, a vaginal insert medication, represents a routine pharmaceutical delivery under the larger contract vehicle that facilitates efficient medical supply chain operations across the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/27/25 |